Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of MLN8237 in Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc. Identifier:
First received: August 18, 2009
Last updated: July 1, 2013
Last verified: July 2013